I think long-term MPL will face headwinds unless it reduces its reliance on premiums for revenue and diversifies into other businesses. Although people will age and may live longer, morbidity and health service utilisation may not decrease, and they may face an uphill battle to contain claim costs. So the ageing population isn't necessarily a tailwind. Short-term stag seems a given though.
- Forums
- IPOs
- Medibank Broker Firm Allocations
Medibank Broker Firm Allocations, page-247
Featured News
Featured News
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Dr. Hartley Atkinson, MD
Dr. Hartley Atkinson
MD
Previous Video
Next Video
SPONSORED BY The Market Online